Strategy for treatment of fibrosis in systemic sclerosis: Present and future
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Strategy for treatment of fibrosis in systemic sclerosis: Present and future
Authors
Keywords
-
Journal
JOURNAL OF DERMATOLOGY
Volume 43, Issue 1, Pages 46-55
Publisher
Wiley
Online
2016-01-06
DOI
10.1111/1346-8138.13026
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- IL-6 as a keystone cytokine in health and disease
- (2015) Christopher A Hunter et al. NATURE IMMUNOLOGY
- Long-term efficacy of B cell depletion therapy on lung and skin involvement in diffuse systemic sclerosis
- (2015) Silvia L. Bosello et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) group
- (2014) Suzana Jordan et al. ANNALS OF THE RHEUMATIC DISEASES
- Stem cell therapies for systemic sclerosis
- (2014) Paola Cipriani et al. BRITISH JOURNAL OF HAEMATOLOGY
- Autologous Hematopoietic Stem Cell Transplantation vs Intravenous Pulse Cyclophosphamide in Diffuse Cutaneous Systemic Sclerosis
- (2014) Jacob M. van Laar et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effects of the immunosuppressant rapamycin on the expression of human α2(I) collagen and matrix metalloproteinase 1 genes in scleroderma dermal fibroblasts
- (2014) Zenshiro Tamaki et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- Successful experience of rituximab therapy for systemic sclerosis-associated interstitial lung disease with concomitant systemic lupus erythematosus
- (2014) Hayakazu Sumida et al. JOURNAL OF DERMATOLOGY
- Intravenous Immunoglobulin May Be an Effective Therapy for Refractory, Active Diffuse Cutaneous Systemic Sclerosis
- (2014) C. L. Poelman et al. JOURNAL OF RHEUMATOLOGY
- Digital ulcers as a sentinel sign for early internal organ involvement in very early systemic sclerosis
- (2014) C. Bruni et al. RHEUMATOLOGY
- Treatment of systemic sclerosis with tocilizumab
- (2014) M. Fernandes das Neves et al. RHEUMATOLOGY
- Low-dose oral imatinib in the treatment of systemic sclerosis interstitial lung disease unresponsive to cyclophosphamide: a phase II pilot study
- (2014) Paolo Fraticelli et al. ARTHRITIS RESEARCH & THERAPY
- Prediction of Pulmonary Complications and Long-Term Survival in Systemic Sclerosis
- (2014) Svetlana I. Nihtyanova et al. Arthritis & Rheumatology
- Preliminary analysis of the Very Early Diagnosis of Systemic Sclerosis (VEDOSS) EUSTAR multicentre study: evidence for puffy fingers as a pivotal sign for suspicion of systemic sclerosis
- (2013) Tünde Minier et al. ANNALS OF THE RHEUMATIC DISEASES
- 2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative
- (2013) Frank van den Hoogen et al. ANNALS OF THE RHEUMATIC DISEASES
- 2013 Classification Criteria for Systemic Sclerosis: An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative
- (2013) Frank van den Hoogen et al. ARTHRITIS AND RHEUMATISM
- Serum Interleukin 6 Is Predictive of Early Functional Decline and Mortality in Interstitial Lung Disease Associated with Systemic Sclerosis
- (2013) A. De Lauretis et al. JOURNAL OF RHEUMATOLOGY
- Scleroderma pathogenesis: a pivotal role for fibroblasts as effector cells
- (2013) Adrian J Gilbane et al. ARTHRITIS RESEARCH & THERAPY
- Clinical and pathological significance of interleukin 6 overexpression in systemic sclerosis
- (2012) Korsa Khan et al. ANNALS OF THE RHEUMATIC DISEASES
- Tumor necrosis factor-costimulated T lymphocytes from patients with systemic sclerosis trigger collagen production in fibroblasts
- (2012) Thomas Hügle et al. ARTHRITIS AND RHEUMATISM
- Imatinib mesylate in scleroderma-associated diffuse skin fibrosis: a phase II multicentre randomized double-blinded controlled trial
- (2012) S. Prey et al. BRITISH JOURNAL OF DERMATOLOGY
- Interleukin 6 in Systemic Sclerosis and Potential Implications for Targeted Therapy
- (2012) C. MUANGCHAN et al. JOURNAL OF RHEUMATOLOGY
- Influence of the IL6 Gene in Susceptibility to Systemic Sclerosis
- (2012) M. C. CENIT et al. JOURNAL OF RHEUMATOLOGY
- Two-year Results of an Open Pilot Study of a 2-treatment Course with Rituximab in Patients with Early Systemic Sclerosis with Diffuse Skin Involvement
- (2012) V. SMITH et al. JOURNAL OF RHEUMATOLOGY
- Potential Immunologic Targets for Treating Fibrosis in Systemic Sclerosis: A Review Focused on Leukocytes and Cytokines
- (2012) Minoru Hasegawa et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Therapeutic Inhibition of Tyrosine Kinases in Systemic Sclerosis: A Review of Published Experience on the First 108 Patients Treated with Imatinib
- (2012) Vasiliki-Kalliopi Bournia et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Blockade of Interleukin-6 Receptor Alleviates Disease in Mouse Model of Scleroderma
- (2011) Shun Kitaba et al. AMERICAN JOURNAL OF PATHOLOGY
- Long-term experience of mycophenolate mofetil for treatment of diffuse cutaneous systemic sclerosis
- (2011) E. N. Le et al. ANNALS OF THE RHEUMATIC DISEASES
- Pirfenidone suppresses keloid fibroblast-embedded collagen gel contraction
- (2011) Masuyoshi Saito et al. ARCHIVES OF DERMATOLOGICAL RESEARCH
- A one-year, phase I/IIa, open-label pilot trial of imatinib mesylate in the treatment of systemic sclerosis-associated active interstitial lung disease
- (2011) Dinesh Khanna et al. ARTHRITIS AND RHEUMATISM
- Immunization with DNA topoisomerase I and Freund's complete adjuvant induces skin and lung fibrosis and autoimmunity via interleukin-6 signaling
- (2011) Ayumi Yoshizaki et al. ARTHRITIS AND RHEUMATISM
- Serum IL-33 levels are raised in patients with systemic sclerosis: association with extent of skin sclerosis and severity of pulmonary fibrosis
- (2011) Koichi Yanaba et al. CLINICAL RHEUMATOLOGY
- Pirfenidone
- (2011) Natalie J. Carter DRUGS
- Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database
- (2010) A. J. Tyndall et al. ANNALS OF THE RHEUMATIC DISEASES
- Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research Group
- (2010) J. Avouac et al. ANNALS OF THE RHEUMATIC DISEASES
- Skin thickness progression rate: a predictor of mortality and early internal organ involvement in diffuse scleroderma
- (2010) R. T. Domsic et al. ANNALS OF THE RHEUMATIC DISEASES
- Treatment with rapamycin prevents fibrosis in tight-skin and bleomycin-induced mouse models of systemic sclerosis
- (2010) Ayumi Yoshizaki et al. ARTHRITIS AND RHEUMATISM
- Soluble interleukin-2 receptor, interleukin-2 and interleukin-4 in sera and supernatants from patients with progressive systemic sclerosis
- (2010) G. FAMULARO et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Mycophenolate mofetil in systemic sclerosis-associated interstitial lung disease
- (2010) Athanasios Koutroumpas et al. CLINICAL RHEUMATOLOGY
- The skin of patients with systemic sclerosis softened during the treatment with anti-IL-6 receptor antibody tocilizumab
- (2010) Y. Shima et al. RHEUMATOLOGY
- B cell depletion in diffuse progressive systemic sclerosis: safety, skin score modification and IL-6 modulation in an up to thirty-six months follow-up open-label trial
- (2010) Silvia Bosello et al. ARTHRITIS RESEARCH & THERAPY
- EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR)
- (2009) O Kowal-Bielecka et al. ANNALS OF THE RHEUMATIC DISEASES
- Treatment with imatinib prevents fibrosis in different preclinical models of systemic sclerosis and induces regression of established fibrosis
- (2009) Alfiya Akhmetshina et al. ARTHRITIS AND RHEUMATISM
- Rapamycin versus methotrexate in early diffuse systemic sclerosis: Results from a randomized, single-blind pilot study
- (2009) Tien-I Karleen Su et al. ARTHRITIS AND RHEUMATISM
- Experience with rituximab in scleroderma: results from a 1-year, proof-of-principle study
- (2009) Dimitrios Daoussis et al. RHEUMATOLOGY
- Is There a Role for B-cell Depletion as Therapy for Scleroderma? A Case Report and Review of the Literature
- (2009) Dimitrios Daoussis et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Rituximab in diffuse cutaneous systemic sclerosis: an open-label clinical and histopathological study
- (2008) V Smith et al. ANNALS OF THE RHEUMATIC DISEASES
- Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud's phenomenon to systemic sclerosis: A twenty-year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosis
- (2008) Martial Koenig et al. ARTHRITIS AND RHEUMATISM
- B-lymphocyte contributions to human autoimmune disease
- (2008) Koichi Yanaba et al. IMMUNOLOGICAL REVIEWS
- Determinants of Morbidity and Mortality of Systemic Sclerosis in Canada
- (2008) Firas F. Al-Dhaher et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Survival and causes of death in 366 Hungarian patients with systemic sclerosis
- (2007) L Czirjak et al. ANNALS OF THE RHEUMATIC DISEASES
- Effect of Mycophenolate Mofetil on Pulmonary Function in Scleroderma-Associated Interstitial Lung Disease
- (2007) Anthony J. Gerbino et al. CHEST
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More